Recent exceptional negative changes in investment behavior have affected HUTCHMED (China) Limited (NASDAQ: HCM): negative upside/downside volume developed, and the stock fell on very heavy volume.
HUTCHMED (China) Limited (NASDAQ: HCM) suffers from significant negative changes in fundamentals: the consensus estimate for December, 2025 decreased significantly, and significant quarterly earnings deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
HUTCHMED (China) Limited has a current Value Trend Rating of F (Lowest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. HUTCHMED (China) Limited has a neutral Power Rating of 40 but a very low Appreciation Score of 11, producing the Lowest Value Trend Rating.
Recent Price Action
HUTCHMED (China) Limited (NASDAQ: HCM) stock suffered a large decline of -7.7% on 1/15/25. The stock closed at $13.85. Moreover, trading volume in this decline was exceptionally high at 217% of normal. The stock has been weak relative to the market over the last nine months and has declined -12.4% during the last week.
Be the first to comment